Home care of acute leukaemia patients: From active therapy to end-of-life and palliative care. The 3-year experience of a single centre

Isabella Capodanno, Enrica Tamagnini, Pierluigi Alfieri, Katia Codeluppi, Stefano Luminari, Francesco Merli

Research output: Contribution to journalArticle

Abstract

Purpose: The aim of the study was to evaluate the feasibility and the potential effects of the Haematological Home Care (HHC) programme for acute leukaemia (AL) patients, either in active chemotherapy or in the terminal phase of disease. Methods: We retrospectively assessed a group of AL patients assisted at home in terms of number of hospitalisations, accesses to emergency department and place of death. We also used historical data to evaluate potential effects of HHC. Results: The study group consisted of 44 patients, 36 of whom (82%) required palliative treatment, and eight (18%) had ongoing active chemotherapy. The mean number of hospitalisations was 0.64 (range 0-7) per patient, and the number of emergency department (ED) visits was 0.82 (range 0-4) per patient. Place of death was at home for 51.4% of patients and in hospital for 40.5%. Considering a historical group of 17 patients assisted at home the rate of hospitalisations and ED visits were 2.53 (range 0-9) and one (range 0-3), respectively. Place of death was home and hospital in 6% and 65%, respectively. Conclusions: Haematological Home Care for AL patients is feasible and has potential positive effects in terms rate of hospitalisations and place of death.

Original languageEnglish
JournalEuropean Journal of Haematology
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Terminal Care
Home Care Services
Palliative Care
Leukemia
Hospitalization
Hospital Emergency Service
Therapeutics
Drug Therapy

Keywords

  • acute leukaemia
  • home care
  • palliative care
  • supportive care

ASJC Scopus subject areas

  • Hematology

Cite this

Home care of acute leukaemia patients : From active therapy to end-of-life and palliative care. The 3-year experience of a single centre. / Capodanno, Isabella; Tamagnini, Enrica; Alfieri, Pierluigi; Codeluppi, Katia; Luminari, Stefano; Merli, Francesco.

In: European Journal of Haematology, 01.01.2019.

Research output: Contribution to journalArticle

@article{a4bcd122c34b4e62bd04a1fe3ead17db,
title = "Home care of acute leukaemia patients: From active therapy to end-of-life and palliative care. The 3-year experience of a single centre",
abstract = "Purpose: The aim of the study was to evaluate the feasibility and the potential effects of the Haematological Home Care (HHC) programme for acute leukaemia (AL) patients, either in active chemotherapy or in the terminal phase of disease. Methods: We retrospectively assessed a group of AL patients assisted at home in terms of number of hospitalisations, accesses to emergency department and place of death. We also used historical data to evaluate potential effects of HHC. Results: The study group consisted of 44 patients, 36 of whom (82{\%}) required palliative treatment, and eight (18{\%}) had ongoing active chemotherapy. The mean number of hospitalisations was 0.64 (range 0-7) per patient, and the number of emergency department (ED) visits was 0.82 (range 0-4) per patient. Place of death was at home for 51.4{\%} of patients and in hospital for 40.5{\%}. Considering a historical group of 17 patients assisted at home the rate of hospitalisations and ED visits were 2.53 (range 0-9) and one (range 0-3), respectively. Place of death was home and hospital in 6{\%} and 65{\%}, respectively. Conclusions: Haematological Home Care for AL patients is feasible and has potential positive effects in terms rate of hospitalisations and place of death.",
keywords = "acute leukaemia, home care, palliative care, supportive care",
author = "Isabella Capodanno and Enrica Tamagnini and Pierluigi Alfieri and Katia Codeluppi and Stefano Luminari and Francesco Merli",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/ejh.13224",
language = "English",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Home care of acute leukaemia patients

T2 - From active therapy to end-of-life and palliative care. The 3-year experience of a single centre

AU - Capodanno, Isabella

AU - Tamagnini, Enrica

AU - Alfieri, Pierluigi

AU - Codeluppi, Katia

AU - Luminari, Stefano

AU - Merli, Francesco

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: The aim of the study was to evaluate the feasibility and the potential effects of the Haematological Home Care (HHC) programme for acute leukaemia (AL) patients, either in active chemotherapy or in the terminal phase of disease. Methods: We retrospectively assessed a group of AL patients assisted at home in terms of number of hospitalisations, accesses to emergency department and place of death. We also used historical data to evaluate potential effects of HHC. Results: The study group consisted of 44 patients, 36 of whom (82%) required palliative treatment, and eight (18%) had ongoing active chemotherapy. The mean number of hospitalisations was 0.64 (range 0-7) per patient, and the number of emergency department (ED) visits was 0.82 (range 0-4) per patient. Place of death was at home for 51.4% of patients and in hospital for 40.5%. Considering a historical group of 17 patients assisted at home the rate of hospitalisations and ED visits were 2.53 (range 0-9) and one (range 0-3), respectively. Place of death was home and hospital in 6% and 65%, respectively. Conclusions: Haematological Home Care for AL patients is feasible and has potential positive effects in terms rate of hospitalisations and place of death.

AB - Purpose: The aim of the study was to evaluate the feasibility and the potential effects of the Haematological Home Care (HHC) programme for acute leukaemia (AL) patients, either in active chemotherapy or in the terminal phase of disease. Methods: We retrospectively assessed a group of AL patients assisted at home in terms of number of hospitalisations, accesses to emergency department and place of death. We also used historical data to evaluate potential effects of HHC. Results: The study group consisted of 44 patients, 36 of whom (82%) required palliative treatment, and eight (18%) had ongoing active chemotherapy. The mean number of hospitalisations was 0.64 (range 0-7) per patient, and the number of emergency department (ED) visits was 0.82 (range 0-4) per patient. Place of death was at home for 51.4% of patients and in hospital for 40.5%. Considering a historical group of 17 patients assisted at home the rate of hospitalisations and ED visits were 2.53 (range 0-9) and one (range 0-3), respectively. Place of death was home and hospital in 6% and 65%, respectively. Conclusions: Haematological Home Care for AL patients is feasible and has potential positive effects in terms rate of hospitalisations and place of death.

KW - acute leukaemia

KW - home care

KW - palliative care

KW - supportive care

UR - http://www.scopus.com/inward/record.url?scp=85062962347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062962347&partnerID=8YFLogxK

U2 - 10.1111/ejh.13224

DO - 10.1111/ejh.13224

M3 - Article

AN - SCOPUS:85062962347

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

ER -